AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 59 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,342,000 | +8.7% | 240,000 | -8.9% | 0.42% | +59.2% |
| Q4 2021 | $1,235,000 | -56.1% | 263,400 | -42.2% | 0.26% | -50.2% |
| Q3 2021 | $2,816,000 | -34.0% | 455,600 | -29.6% | 0.53% | -25.7% |
| Q2 2021 | $4,264,000 | -30.2% | 647,000 | -22.5% | 0.71% | -21.2% |
| Q1 2021 | $6,112,000 | +1702.9% | 835,000 | +1320.1% | 0.90% | +1940.9% |
| Q4 2020 | $339,000 | – | 58,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,952,958 | $22,809,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 1,151,175 | $6,642,000 | 0.47% |
| X-Square Capital, LLC | 75,952 | $438,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 68,092 | $393,000 | 0.08% |
| WealthTrust Axiom LLC | 22,347 | $128,000 | 0.05% |
| Opaleye Management Inc. | 58,800 | $339,000 | 0.04% |
| Trexquant Investment LP | 64,838 | $374,000 | 0.04% |
| PDT Partners, LLC | 60,117 | $347,000 | 0.02% |
| PERSONAL CFO SOLUTIONS, LLC | 13,000 | $75,000 | 0.02% |
| CVI Holdings, LLC | 13,171 | $76,000 | 0.01% |